936563-86-9 Usage
Molecular structure
The compound has a complex structure consisting of a piperidinecarboxylic acid core, a 1,1-dimethylethyl ester side chain, a pyrazolo[3,4-d]pyrimidin-1-yl] moiety, and amino and phenoxyphenyl substituents.
Core component
The core component of the compound is piperidinecarboxylic acid, which is a heterocyclic compound with a nitrogen atom in the ring.
Ester side chain
The compound has a 1,1-dimethylethyl ester side chain, which is an organic functional group formed by the esterification of a carboxylic acid with an alcohol.
Pyrazolo[3,4-d]pyrimidin-1-yl] moiety
The compound contains a pyrazolo[3,4-d]pyrimidin-1-yl] moiety, which is a fused heterocyclic ring system consisting of a pyrazole and a pyrimidine ring.
Amino and phenoxyphenyl substituents
The compound has amino and phenoxyphenyl substituents, which are organic functional groups that can influence the compound's biological activity and properties.
Pharmaceutical applications
Due to its complex structure and various functional groups, the compound may have potential pharmaceutical applications, affecting different biological pathways.
Safety and handling
It is important to handle and use this compound with caution, following proper safety protocols and regulations to avoid any adverse effects or hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 936563-86-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,5,6 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 936563-86:
(8*9)+(7*3)+(6*6)+(5*5)+(4*6)+(3*3)+(2*8)+(1*6)=209
209 % 10 = 9
So 936563-86-9 is a valid CAS Registry Number.
936563-86-9Relevant articles and documents
BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF
-
, (2021/02/12)
Provided herein are benzenesulfonamide derivatives having Formula (III), pharmaceutical compositions comprising said compounds, and method for using said compounds for disrupting proteins/polypeptides, protein/polypeptide function, and for the treatment of diseases through the disruption of proteins or polypeptides involved in the etiology of the disease. Said compounds comprise fluorinated benzene sulfonamide structures.
Preparation method of Bruton's tyrosine kinase inhibitor
-
Paragraph 0051-0053, (2017/08/31)
The invention relates to the field of drug synthesis, specifically to a preparation method of a Bruton's tyrosine kinase inhibitor. The new method comprises: carrying out a dark reaction between 4-amino-3-(4-phenoxylphenyl)-1H-pyridino(3,4-d)pyrimidine an
KINASE INHIBITORS
-
Paragraph 0432, (2014/11/11)
Provided herein are kinase inhibiting compounds and methods of using the same.